NCT04672512View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

115

Participants

Timeline

Start Date

October 23, 2020

Primary Completion Date

January 17, 2022

Study Completion Date

January 17, 2022

Conditions
Healthy
Interventions
DRUG

CORT125329 lipid capsule formulation

CORT125329 lipid capsule formulation 1 or 2 for oral administration

DRUG

Placebo

Placebo matching CORT125329 lipid capsule formulation 1 or 2 for oral administration

DRUG

Prednisone

Prednisone tablet for oral administration

Trial Locations (1)

NG11 6JS

Quotient Sciences, Ruddington

Sponsors
All Listed Sponsors
lead

Corcept Therapeutics

INDUSTRY